Brief: Alembic Pharmaceuticals Says USFDA Issues Form 483 With 4 Observations After Inspection
March 8 (Reuters) - Alembic Pharmaceuticals Ltd
ALEM.NS :
* USFDA HAS CONDUCTED AN INSPECTION AT OUR ONCOLOGY
FORMULATION
FACILITY AT PANELAV
* USFDA ISSUED A FORM 483 WITH FOUR PROCEDURAL OBSERVATION
Source text for Eikon: ID:nBSE96jTwf
Further company coverage: ALEM.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alembic Pharmaceuticals
See all newsIndia's Alembic Pharma rises after US FDA approves herpesvirus drug
Brief: Alembic Pharmaceuticals Receives USFDA Final Approval For Valganciclovir Oral Solution 50 Mg/Ml
Brief: Alembic Pharmaceuticals Completes USFDA Bioequivalence Inspection At Vadodara With No Observations
India's Alembic Pharma gains as brokerages optimistic after quarterly profit rise
India's Alembic Pharma posts quarterly profit rise on strong generics demand